Operating platform

One access layer between origin supply and qualified review.

Aura Med keeps the first conversation focused on category, files, route and counterpart qualification.

Laboratory vials arranged for sample review
Origin

Producer and category screening

Review producer background, export readiness and basic file availability.

Dossier

Document readiness

Organise the core files that a buyer, pharmacy route or quality team expects first.

Route

Country and channel review

Map intended use, counterpart qualification and market constraints before escalation.

Interface

Qualified conversations

Move introductions forward only when role, route and files are clear enough.

What buyers expect to see

Broad categories, simple checkpoints.

Regulated medical cannabis and adjacent healthcare categories often need the same first-pass discipline: route, files and role clarity before commercial claims.

Supplier qualification

Producer background, facility references, export readiness and document availability.

Analytical file review

Core analytical files, specifications, stability notes and missing evidence.

GMP / GACP alignment

Whether current production and cultivation references match buyer expectations.

Import / export readiness

Route assumptions, target country, permitted professional use and license position.

Packaging and labelling assumptions

White-label, bulk, finished format and market-specific labelling considerations.

Storage and distribution handoff

GDP, warehousing, batch release and distribution questions routed to qualified partners where required.

Decision boundary

Clear scope before commercial exposure.

What Aura Med checks first

Role, target country, intended use, category sensitivity, file state and counterpart qualification.

What Aura Med does not replace

Formal legal advice, licensing decisions, product registration, medical claims review or national regulatory determinations.

When a case should pause

If country, qualification, documents or lawful intended use are unclear, Aura Med returns a blocker list before partner exposure.

B2B decision psychology

What we remove from the first conversation.

Wrong-intro anxiety

Teams hesitate when the first introduction could create legal review, procurement rework or credibility loss.

Open-ended document requests

Instead of "send everything", Aura Med keeps the first file request tied to one decision: proceed, pause or collect-files.

Unclear internal owner

Every first-pass outcome names the next likely owner: commercial, legal, quality, procurement or supplier-side documentation.